Literature DB >> 23009867

Transperineal management for postoperative and radiation rectourethral fistulas.

Bryan B Voelzke1, Jack W McAninch, Benjamin N Breyer, Allison S Glass, Julio Garcia-Aguilar.   

Abstract

PURPOSE: The rectal sphincter preserving transperineal approach has been increasingly used successfully. We analyzed our experience with this surgical approach. A secondary aim was to evaluate the surgical outcome of energy ablative rectourethral fistulas without a concomitant interposition muscle flap.
MATERIALS AND METHODS: We identified all patients with rectourethral fistula who underwent rectal sphincter preserving transperineal repair from 1998 to 2011. Re-approximation of the urethral mucosa, posterior anastomotic urethroplasty or partial/total prostatectomy with urethrovesical anastomosis was performed for urinary closure. The fistula cohort was divided into 2 groups, including postoperative and energy ablative fistulas, respectively. Success after perineal rectourethral fistula repair was defined as resolution after the first attempt at repair.
RESULTS: A total of 23 patients underwent rectal sphincter preserving, transperineal rectourethral fistula repair. In the postoperative fistula cohort the fistula was successfully resolved in all 10 patients. A dartos interposition muscle flap was used in 2 of 10 patients. In the energy ablative cohort the fistula was successfully closed in 8 of 13 patients. An interposition muscle flap was not placed in 8 patients with an energy ablative fistula, of whom success was achieved in 5. Two of the 5 patients with an energy ablative fistula and a successful outcome without a concomitant interposition muscle flap had urinary extravasation, necessitating temporary catheterization.
CONCLUSIONS: Rectal sphincter preserving transperineal repair is a successful surgical method to repair postoperative and energy ablative rectourethral fistulas. An interposition muscle flap should be considered in the setting of energy ablative rectourethral fistulas to increase successful outcomes.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23009867      PMCID: PMC3570634          DOI: 10.1016/j.juro.2012.08.238

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Rectourethral fistulas.

Authors:  Tomás Hanus
Journal:  Int Braz J Urol       Date:  2002 Jul-Aug       Impact factor: 1.541

2.  York-Mason procedure for repair of recto-urinary fistulae: a 40-year experience.

Authors:  David A Hadley; Andrew Southwick; Richard G Middleton
Journal:  BJU Int       Date:  2011-10-28       Impact factor: 5.588

3.  Urorectal fistulae following the treatment of prostate cancer.

Authors:  Anthony R Mundy; Daniela E Andrich
Journal:  BJU Int       Date:  2010-09-30       Impact factor: 5.588

4.  Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft.

Authors:  Alex J Vanni; Jill C Buckley; Leonard N Zinman
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

5.  Dartos muscle interposition flap for the treatment of rectourethral fistulas.

Authors:  Madhulika G Varma; Jennifer Y Wang; Julio Garcia-Aguilar; Andrew A Shelton; Jack W McAninch; Stanley M Goldberg
Journal:  Dis Colon Rectum       Date:  2007-11       Impact factor: 4.585

6.  Gracilis muscle interposition for the treatment of rectourethral, rectovaginal, and pouch-vaginal fistulas: results in 53 patients.

Authors:  Steven D Wexner; Dan E Ruiz; Jill Genua; Juan J Nogueras; Eric G Weiss; Oded Zmora
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

7.  30 years of experience with York-Mason repair of recto-urinary fistulas.

Authors:  Todd D Renschler; Richard G Middleton
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

  7 in total
  11 in total

1.  Transanal endoscopic microsurgery for surgical repair of rectovesical fistula following radical prostatectomy.

Authors:  Eiji Kanehira; Takashi Tanida; Aya Kamei; Masafumi Nakagi; Mitsuharu Iwasaki; Hirofumi Shimizu
Journal:  Surg Endosc       Date:  2014-07-25       Impact factor: 4.584

Review 2.  Management of Complex Perineal Fistula Disease.

Authors:  Ricardo Tadayoshi Akiba; Fabio Gontijo Rodrigues; Giovanna da Silva
Journal:  Clin Colon Rectal Surg       Date:  2016-06

Review 3.  Rectourethral Fistula Management.

Authors:  Daniel Ramírez-Martín; José Jara-Rascón; Teresa Renedo-Villar; Carlos Hernández-Fernández; Enrique Lledó-García
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

4.  York Mason procedure to repair iatrogenic rectourinary fistula: our experience.

Authors:  Cristina Falavolti; Federico Sergi; Ervin Shehu; Maurizio Buscarini
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

5.  Management of iatrogenic urorectal fistulae in men with pelvic cancer.

Authors:  Francisco E Martins; Natália M Martins; Luís Campos Pinheiro; Luís Ferraz; Luís Xambre; Tomé M Lopes
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

6.  [Fistula surgery].

Authors:  C M Rosenbaum; M W Vetterlein; M Fisch
Journal:  Urologe A       Date:  2020-04       Impact factor: 0.639

7.  Three distinct urethral fistulae 35 years after pelvic radiation.

Authors:  Arindam Sharma; Michael P Kurtz; Jairam R Eswara
Journal:  Nephrourol Mon       Date:  2014-02-22

Review 8.  Management of acquired rectourethral fistulas in adults.

Authors:  Shulian Chen; Rang Gao; Hong Li; Kunjie Wang
Journal:  Asian J Urol       Date:  2018-01-31

9.  The Ligation of Intersphincteric Fistula Tract Technique: A Preliminary Experience.

Authors:  Pasquale Cianci; Nicola Tartaglia; Alberto Fersini; Libero Luca Giambavicchio; Vincenzo Neri; Antonio Ambrosi
Journal:  Ann Coloproctol       Date:  2019-10-31

10.  Endoscopic treatment of a rectovesical fistula following radical prostatectomy by over-the-scope clip (OTSC).

Authors:  Milos Brodak; Josef Kosine; Ilja Tachecí; Jaroslav Pacovsky
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-14       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.